Laboratory Diagnosis of Mpox, Central African Republic, 2016-2022.
Garba-Ouangole S., Bourner J., Mbrenga F., Gonofio E., Selekon B., Manirakiza A., Kalthan E., Malaka C., Boum Y., Olliaro P., Nakouné E.
During 2016-2022, PCR testing confirmed 100 mpox cases among 302 suspected cases in the Central African Republic. The highest detection rates were from active lesions (40%) and scabs (36%); cycle thresholds were lower (≈18) than those for blood samples (≈33). Results were consistent for generic primer- and clade I primer-specific PCR tests.